Companies › INBS

INTELLIGENT BIO SOLUTIONS IN (INBS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001725430 · EDGAR filings · Updated 2026-07-23

INTELLIGENT BIO SOLUTIONS IN (INBS) has reported institutional ownership of 8.7%, with 9 institutional managers holding positions valued at $696.9K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-23 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Current report (8-K) filed
• 2026-06-16 — Current report (8-K) filed
• 2026-06-02 — Current report (8-K) filed
• 2026-05-15 — SCHEDULE 13G filed
• 2026-05-14 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INTELLIGENT BIO SOLUTIONS IN has 9 institutional holders and institutional ownership of 8.7%.

Insider activity

Insiders reported 8 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ABVC BIOPHARMA INC (ABVC) · Cocrystal Pharma Inc (COCP) · ERNEXA THERAPEUTICS INC (ERNA) · GENENTA SCIENCE S P A (GNTA) · BONE BIOLOGICS CORP (BBLG) · Exicure Inc (XCUR)